APD597 (JNJ-38431055) is an orally active agonist of GPR119. APD597 exhibits reduced CYP2C9 inhibition with an IC50 of 5.8 µM. APD597 can be studied in research for type 2 diabetes[1][2][3].
Molecular Weight:
479.55
Purity:
99.97
CAS Number:
[897732-93-3]
Formula:
C21H29N5O6S
Target:
GPR119
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted